Cargando…
Chylous Ascites: Evaluation and Management
Chylous ascites refers to the accumulation of lipid-rich lymph in the peritoneal cavity due to disruption of the lymphatic system secondary to traumatic injury or obstruction. Worldwide, abdominal malignancy, cirrhosis, and tuberculosis are the commonest causes of CA in adults, the latter being most...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890871/ https://www.ncbi.nlm.nih.gov/pubmed/27335837 http://dx.doi.org/10.1155/2014/240473 |
_version_ | 1782435173927747584 |
---|---|
author | Al-Busafi, Said A. Ghali, Peter Deschênes, Marc Wong, Philip |
author_facet | Al-Busafi, Said A. Ghali, Peter Deschênes, Marc Wong, Philip |
author_sort | Al-Busafi, Said A. |
collection | PubMed |
description | Chylous ascites refers to the accumulation of lipid-rich lymph in the peritoneal cavity due to disruption of the lymphatic system secondary to traumatic injury or obstruction. Worldwide, abdominal malignancy, cirrhosis, and tuberculosis are the commonest causes of CA in adults, the latter being most prevalent in developing countries, whereas congenital abnormalities of the lymphatic system and trauma are commonest in children. The presence of a milky, creamy appearing ascitic fluid with triglyceride content above 200 mg/dL is diagnostic, and, in the majority of cases, unless there is a strong suspicion of malignancy, further investigations are not required in patients with cirrhosis. If an underlying cause is identified, targeted therapy is possible, but most cases will be treated conservatively, with dietary support including high-protein and low-fat diets supplemented with medium-chain triglycerides, therapeutic paracentesis, total parenteral nutrition, and somatostatins. Rarely, resistant cases have been treated by transjugular intrahepatic portosystemic shunt, surgical exploration, or peritoneovenous shunt. |
format | Online Article Text |
id | pubmed-4890871 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-48908712016-06-22 Chylous Ascites: Evaluation and Management Al-Busafi, Said A. Ghali, Peter Deschênes, Marc Wong, Philip ISRN Hepatol Review Article Chylous ascites refers to the accumulation of lipid-rich lymph in the peritoneal cavity due to disruption of the lymphatic system secondary to traumatic injury or obstruction. Worldwide, abdominal malignancy, cirrhosis, and tuberculosis are the commonest causes of CA in adults, the latter being most prevalent in developing countries, whereas congenital abnormalities of the lymphatic system and trauma are commonest in children. The presence of a milky, creamy appearing ascitic fluid with triglyceride content above 200 mg/dL is diagnostic, and, in the majority of cases, unless there is a strong suspicion of malignancy, further investigations are not required in patients with cirrhosis. If an underlying cause is identified, targeted therapy is possible, but most cases will be treated conservatively, with dietary support including high-protein and low-fat diets supplemented with medium-chain triglycerides, therapeutic paracentesis, total parenteral nutrition, and somatostatins. Rarely, resistant cases have been treated by transjugular intrahepatic portosystemic shunt, surgical exploration, or peritoneovenous shunt. Hindawi Publishing Corporation 2014-02-03 /pmc/articles/PMC4890871/ /pubmed/27335837 http://dx.doi.org/10.1155/2014/240473 Text en Copyright © 2014 Said A. Al-Busafi et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Al-Busafi, Said A. Ghali, Peter Deschênes, Marc Wong, Philip Chylous Ascites: Evaluation and Management |
title | Chylous Ascites: Evaluation and Management |
title_full | Chylous Ascites: Evaluation and Management |
title_fullStr | Chylous Ascites: Evaluation and Management |
title_full_unstemmed | Chylous Ascites: Evaluation and Management |
title_short | Chylous Ascites: Evaluation and Management |
title_sort | chylous ascites: evaluation and management |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890871/ https://www.ncbi.nlm.nih.gov/pubmed/27335837 http://dx.doi.org/10.1155/2014/240473 |
work_keys_str_mv | AT albusafisaida chylousascitesevaluationandmanagement AT ghalipeter chylousascitesevaluationandmanagement AT deschenesmarc chylousascitesevaluationandmanagement AT wongphilip chylousascitesevaluationandmanagement |